IFI16 and systemic lupus erythematosus: More recently, we and others have found that IFI16 can also be aberrantly expressed in chronically inflamed tissues such as the intestinal epithelium of patients with inflammatory bowel disease (IBD) [6,7] and the epidermis and inflammatory dermal infiltrates of systemic lupus erythematosus (SLE) patients [8,9].